Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Intangibles (2016 - 2026)

Nutex Health (NUTX) has disclosed Intangibles for 11 consecutive years, with $20.9 million as the latest value for Q1 2026.

  • For Q1 2026, Intangibles rose 37.49% year-over-year to $20.9 million; the TTM value through Mar 2026 reached $20.9 million, up 37.49%, while the annual FY2025 figure was $21.2 million, 36.7% up from the prior year.
  • Intangibles hit $20.9 million in Q1 2026 for Nutex Health, down from $21.2 million in the prior quarter.
  • Across five years, Intangibles topped out at $23.9 million in Q3 2023 and bottomed at $6.4 million in Q1 2022.
  • Average Intangibles over 5 years is $19.1 million, with a median of $20.9 million recorded in 2026.
  • Year-over-year, Intangibles skyrocketed 3174.11% in 2022 and then tumbled 34.64% in 2025.
  • Nutex Health's Intangibles stood at $22.4 million in 2022, then dropped by 8.22% to $20.5 million in 2023, then dropped by 24.29% to $15.5 million in 2024, then skyrocketed by 36.7% to $21.2 million in 2025, then dropped by 1.53% to $20.9 million in 2026.
  • According to Business Quant data, Intangibles over the past three periods came in at $20.9 million, $21.2 million, and $21.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.